Newborn screening tests

Newborn screening — a worldwide programme

Newborn screening tests are part of a worldwide practice to detect rare but serious health problems (genetic or metabolic disorders) in newborn babies. Early diagnosis of these conditions enables treatment to begin at the earliest opportunity and reduces the ill effects of these disorders throughout life. Publicly funded newborn screening has been available in Australia since the late 1960s.

How is newborn screening carried out?

The newborn screening test is normally carried out by the midwife at the hospital where you have your baby. A few drops of blood are taken from your baby’s heel and collected onto a special card called a Guthrie card. The dried blood sample is then sent to the local screening laboratory for testing. The test is performed between 48 and 72 hours after the birth. If you have your baby at home or leave the hospital within 48 hours, a midwife may collect your baby’s blood sample at home approximately 4 days after the birth.

Soon after your baby is born, a newborn hearing test will also be offered. Although only one or 2 in every 1000 babies in Australia have significant hearing loss, early identification means that these infants can have access to the services they need as soon as possible. Your baby may be tested while you are in hospital, or testing may be done at an outpatient clinic or local community centre after you both have been discharged.

Which conditions are tested as part of newborn screening?

For several decades, babies have been screened for phenylketonuria, congenital hypothyroidism, cystic fibrosis and galactosaemia. However, recent developments in technology (known as tandem mass spectrometry [TMS]) mean that over 30 different disorders can now be detected using blood spots, including those affecting fat metabolism (fatty acid oxidation defects [FAOD]). Although rare, once detected these disorders can usually be treated by modifying the baby’s diet and avoiding periods of fasting.

Phenylketonuria

Phenylketonuria is a rare condition affecting approximately one in 15,000 babies in Australia. It is the most common amino acid metabolism disorder. (Amino acids are the building blocks of proteins.) It occurs when a baby is unable to break down a particular amino acid called phenylalanine. If left untreated, phenylketonuria causes high levels of phenylalanine to accumulate in the blood, resulting in severe brain damage. Detection at birth means that babies can be treated with special milk and eventually a special diet which allows them to grow and develop normally.

Congenital hypothyroidism

Congenital hypothyroidism affects one in about 3300 babies in Australia. It occurs when the thyroid gland is absent, is too small or does not produce enough thyroid hormone. If untreated, it can lead to poor growth and development. Treatment with a daily thyroid hormone tablet allows affected children to grow and develop normally.

Cystic fibrosis

Cystic fibrosis occurs in one in every 2500 babies in Australia. It is an inherited condition that causes the body to produce thicker than normal mucus in the lungs and bowel. Affected children have problems digesting and absorbing food and are prone to serious chest infections. The heel prick test determines whether the amount of a digestive enzyme (a chemical produced by the body to help food digestion) is abnormal. Early detection combined with advances in medical treatment has significantly improved the lives of babies with cystic fibrosis. However, it is rare but possible that not all the genetic changes that cause cystic fibrosis will be picked up on initial testing. Therefore, you should seek medical advice if your baby is failing to gain weight properly, having frequent chest infections or passing frequent bulky, foul-smelling, oily stools.

Galactosaemia

Galactosaemia is a very rare disorder affecting one in 40,000 babies in Australia. It is caused by an accumulation of galactose (a type of sugar found in both breast and cows' milk) in the blood. Serious illness can be prevented when this condition is detected early and babies are given a specially formulated milk.

How do I get the results of the test?

The results of the screening test are usually returned to your doctor or midwife within a week. The exact timing and how the results are returned depends on which state you live in. You will only be contacted if there are concerns with your baby’s test results. About one in every 100 babies needs a second test because the results are inconclusive. Most second tests will give normal results and your doctor or midwife will be notified accordingly. If the test is positive for any of the conditions being tested, your doctor or midwife or the test centre will contact you to arrange an appointment for further tests.

What if I don’t want my baby to be tested?

Screening is not compulsory in Australia, therefore you have the right to refuse the tests on your baby’s behalf. If you refuse the newborn screening tests you may be asked to discuss the situation with a genetic counsellor and you may be asked to sign a written statement showing that you understand the potential risk to the healthy development of your baby.


 

Sponsored links

myDr Newsletter

Get myDr delivered to your inbox
Advertisement
See your doctor for diagnosis MIMS Consumer Health Group logo UBM Medica logo Hitwise Top 10 website This website is certified by Health On the Net Foundation. Click to verify. HealthInsite Quality Health Information ABA audited website - click to view latest stats
This web site is intended for Australian residents and is not a sbstitute for independent professional advice. Information and interactions contained in ths Web site are for infomation purposes only and are not intended ot be used to diagnose,treat , cure or prevent any disease.Further , the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. UBM Medica Australia Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incured by use of or relance on the information made available via or throught myDr whether arising from negligence or otherwise.
See Privacy Policy and Disclaimer.